| CAT No: | CL-BVB-NO-01 |
| CAS No: | NA |
| Mol.F: | C19H18FN5O4 |
| Mol.Wt.: | 399.38 |
| Chemical Name: | (R)-1-((4-((4-fluoro-2-methyl-1-nitroso-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-ol |
| Inventory Status: | Custom synthesis |
This impurity is related to N-Nitroso Brivanib Impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
N-Nitroso Brivanib Impurity is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(R)-1-((4-((4-fluoro-2-methyl-1-nitroso-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-olCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Brivanib Molecular Formula: C19H18FN5O4
Molecular Weight: 399.38
Storage: Store in a cool, dry place.
| Product Name: | N-Nitroso Brivanib Impurity |
| CAS No: | |
| Mol.F.: | C19H18FN5O4 |
| Mol.Wt.: | 399.38 |
Cat. No: CL-BVB-NO-02
CAS No: NA
Mol. F: C22H23FN6O5
Mol. Wt: 470.45
Inv. Status: Custom Synthesis
Cat. No: CL-BVB-001
CAS No: 649735-46-6
Mol. F: C19H19FN4O3
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Cat. No: CL-BVB-002
CAS No: 649735-63-7
Mol. F: C22H24FN5O4
Mol. Wt: 441.5
Inv. Status: Custom Synthesis
Cat. No: CL-BVB-003
CAS No: NA
Mol. F: C19H15D4FN4O3
Mol. Wt: 374.4
Inv. Status: Custom Synthesis
Cat. No: CL-BVB-004
CAS No: NA
Mol. F: C19H13D6FN4O3
Mol. Wt: 376.4
Inv. Status: Custom Synthesis
Cat. No: CL-BVB-005
CAS No: NA
Mol. F: C22H20D4FN5O4
Mol. Wt: 445.5
Inv. Status: Custom Synthesis
Cat. No: CL-BVB-006
CAS No: NA
Mol. F: C22H18D6FN5O4
Mol. Wt: 447.5
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: